Variant report
Variant | rs201445214 |
---|---|
Chromosome Location | chr19:18497005-18497006 |
allele | C/T |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:18485800-18499000 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr19:18491400-18497400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr19:18491600-18497400 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
4 | chr19:18492000-18498800 | Weak transcription | Right Ventricle | heart |
5 | chr19:18493800-18497600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr19:18495600-18497200 | Enhancers | Stomach Mucosa | stomach |
7 | chr19:18495800-18497200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
8 | chr19:18495800-18497400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
9 | chr19:18496200-18497200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr19:18496200-18497400 | Active TSS | Rectal Mucosa Donor 29 | rectum |
11 | chr19:18496400-18498000 | Bivalent Enhancer | Monocytes-CD14+_RO01746 | blood |
12 | chr19:18496400-18498600 | Flanking Active TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
13 | chr19:18496400-18499000 | Enhancers | Primary hematopoietic stem cells | blood |
14 | chr19:18496400-18499000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
15 | chr19:18496400-18499000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
16 | chr19:18496400-18499000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
17 | chr19:18496400-18499000 | Active TSS | Foreskin Melanocyte Primary Cells skin01 | Skin |
18 | chr19:18496600-18497200 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
19 | chr19:18496600-18497400 | Bivalent Enhancer | Primary Natural Killer cells fromperipheralblood | blood |
20 | chr19:18496600-18497800 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
21 | chr19:18496600-18497800 | Active TSS | Rectal Mucosa Donor 31 | rectum |
22 | chr19:18496600-18498200 | Bivalent Enhancer | Primary monocytes fromperipheralblood | blood |
23 | chr19:18496600-18498200 | Flanking Active TSS | Foreskin Fibroblast Primary Cells skin02 | Skin |
24 | chr19:18496800-18497200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
25 | chr19:18496800-18497200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
26 | chr19:18496800-18497200 | Enhancers | Ovary | ovary |
27 | chr19:18496800-18497400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
28 | chr19:18496800-18497400 | Flanking Active TSS | Foreskin Melanocyte Primary Cells skin03 | Skin |
29 | chr19:18496800-18497400 | Active TSS | Duodenum Mucosa | Duodenum |
30 | chr19:18496800-18497400 | Weak transcription | Small Intestine | intestine |
31 | chr19:18496800-18497400 | Enhancers | Spleen | Spleen |
32 | chr19:18496800-18497400 | Active TSS | Hela-S3 | cervix |
33 | chr19:18496800-18497400 | Active TSS | HUVEC | blood vessel |
34 | chr19:18496800-18497400 | Active TSS | Osteobl | bone |
35 | chr19:18496800-18497600 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
36 | chr19:18496800-18497600 | Active TSS | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
37 | chr19:18496800-18497800 | Bivalent/Poised TSS | Duodenum Smooth Muscle | Duodenum |
38 | chr19:18496800-18497800 | Strong transcription | Right Atrium | heart |
39 | chr19:18496800-18498000 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin02 | Skin |
40 | chr19:18496800-18498000 | Flanking Active TSS | Colonic Mucosa | Colon |
41 | chr19:18496800-18498000 | Active TSS | Colon Smooth Muscle | Colon |
42 | chr19:18496800-18498000 | Flanking Active TSS | Pancreas | Pancrea |
43 | chr19:18496800-18498000 | Flanking Active TSS | HMEC | breast |
44 | chr19:18496800-18498200 | Flanking Active TSS | IMR90 fetal lung fibroblasts Cell Line | lung |
45 | chr19:18496800-18499000 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
46 | chr19:18496800-18499400 | Active TSS | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
47 | chr19:18496800-18499400 | Active TSS | A549 | lung |
48 | chr19:18496800-18499600 | Active TSS | K562 | blood |
49 | chr19:18497000-18497200 | Flanking Active TSS | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
50 | chr19:18497000-18497200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |